For at least one Schedule II opioid electronically prescribed using CEHRT during the performance period, the MIPS eligible clinician uses data from CEHRT to conduct a query of a PDMP for prescription drug history, except where prohibited and in accordance with applicable law.
Measure Overview
Objective: e-Prescribing
Measure: For at least one Schedule II opioid electronically prescribed using CEHRT during the performance period, the MIPS eligible clinician uses data from CEHRT to conduct a query of a PDMP for prescription drug history, except where prohibited and in accordance with applicable law.
Measure ID: PI_EP_2
Measure Specifications
Definition of Terms
Measure Reporting
YES/NO
The MIPS eligible clinician must attest YES to conducting a query of a PDMP for at least one Schedule II opioid electronically prescribed using CEHRT to earn the bonus points.
Measure Scoring
- Required for Promoting Interoperability Performance Category Score: No
- Measure Score: N/A
- Eligible for Bonus Score: Yes, 10 points
Note: In order to earn a score greater than zero for the Promoting Interoperability performance category, MIPS eligible clinicians must:
- Complete the activities required by the Security Risk Analysis and High Priority Practices SAFER Guide, submit their complete numerator and denominator or Yes/No data for all required measures, and attest to the Actions to limit or restrict compatibility or interoperability of CEHRT statement.
- Failure to report at least a “1” in all required measures with a numerator or reporting a “No” for a Yes/No response measure (except for the SAFER Guides measure2) will result in a total score of 0 points for the Promoting Interoperability performance category.
Freedom | EHR Workflow
MIPS Conformance Calculation
When generating a MIPS Conformance Report, you must attest YES to conducting a query of a PDMP for at least one Schedule II opioid electronically prescribed using CEHRT to receive credit and earn the bonus points.
How To
Using the Additional Resource Center, log in to the appropriate PDMP and query the patient’s prescription drug history prior to prescribing a new Schedule II opioid prescriptions for the patient during the performance period.
Data Validation
CMS will publish guidance to help clinicians better understand the supporting documentation they should retain when attesting to the MIPS requirements. CMS calls this guidance “MIPS Data Validation Criteria” as it outlines the types of documentation that should be retained to validate the data the provider submits to CMS at the end of the performance period. You must keep documentation for six years subsequent to submission. We suggest reviewing this validation document to ensure you document your work appropriately.